INVO Fertility, Inc. operates as a revenue-generating fertility business. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Follow-Up Questions
Who is the CEO of INVO Fertility Inc?
Mr. Steven Shum is the Chief Executive Officer of INVO Fertility Inc, joining the firm since 2017.
What is the price performance of IVF stock?
The current price of IVF is $0.9033, it has increased 3.66% in the last trading day.
What are the primary business themes or industries for INVO Fertility Inc?
INVO Fertility Inc belongs to Health Care industry and the sector is Health Care
What is INVO Fertility Inc market cap?
INVO Fertility Inc's current market cap is $3.9M
Is INVO Fertility Inc a buy, sell, or hold?
According to wall street analysts, 2 analysts have made analyst ratings for INVO Fertility Inc, including 1 strong buy, 3 buy, 1 hold, 0 sell, and 1 strong sell
